The Biodefense Diplomacy Enhancement Act directs the U.S. State Department to strengthen international cooperation on biological threats and biosecurity, primarily through NATO and allied nations. The Secretary of State must develop two strategies—one focused on NATO biodefense cooperation and another on broader international biotechnology and biosecurity partnerships—and submit them to Congress within 270 days. The bill requires the State Department to coordinate export controls on dual-use biotechnology items that could be used for bioweapons development, promote safety standards in biological research across allied nations, and work with partners to enforce the Biological Weapons Convention. No specific funding amount is allocated in the bill, and the initiatives must be completed within nine months, with congressional briefings provided at the 90-day mark. The legislation primarily affects State Department operations and foreign policy toward NATO members and major U.S. allies, while aiming to prevent the misuse of biotechnology for military purposes globally.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.